Status:

UNKNOWN

Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF

Lead Sponsor:

University Hospitals Coventry and Warwickshire NHS Trust

Conditions:

Idiopathic Pulmonary Fibrosis

Eligibility:

All Genders

16-90 years

Brief Summary

Idiopathic pulmonary fibrosis (IPF) is a chronic and potentially fatal lung disease. As IPF progresses, patients become increasingly breathless with reduced exercise capacity and quality of life. A ca...

Detailed Description

Idiopathic pulmonary fibrosis (IPF) is a chronic and potentially fatal lung disease. As IPF progresses, patients become increasingly breathless with reduced exercise capacity and quality of life. Aver...

Eligibility Criteria

Inclusion

  • Diagnosis of idiopathic pulmonary fibrosis confirmed by a multi-disciplinary team.
  • Aged 16 or over
  • Able to give informed consent to take part
  • Able to undertake both a cycle ergometry test and an incremental shuttle walk test without needing walking aids

Exclusion

  • An inability to give informed consent.
  • Taking part in a research project with a potentially research-modifying intervention
  • Currently pregnant.
  • Currently breastfeeding.
  • Unable to perform an incremental shuttle walk test.
  • Unable to perform an incremental cycle ergometry test.
  • Unable to walk without an aid such as a stick or frame.

Key Trial Info

Start Date :

January 10 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2020

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT03360032

Start Date

January 10 2018

End Date

April 1 2020

Last Update

September 27 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital

Coventry, Warwickshire, United Kingdom, CV2 2DX

Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF | DecenTrialz